DuPLUS: Dual-Prompt Vision-Language Framework for Universal Medical Image Segmentation and Prognosis

Read full text
Authors: Numan Saeed, Tausifa Jan Saleem, Fadillah Adamsyah Maani, Muhammad Ridzuan, Hu Wang, Mohammad K. Yaqub
Cited by: 0
References: 33

Abstract

Deep learning for medical imaging is hampered by task-specific models that lack generalizability and prognostic capabilities, while existing ’universal’ approaches suffer from simplistic conditioning and poor medical semantic understanding. To address these limitations, we introduce DuPLUS, a deep learning framework for efficient multimodal medical image analysis. DuPLUS introduces a novel vision-language framework that leverages hierarchical semantic prompts for fine-grained control over the analysis task, a capability absent in prior universal models. To enable extensibility to other medical tasks, it includes a hierarchical, text-controlled architecture driven by a unique dual-prompt mechanism. For segmentation, DuPLUS is able to generalize across three imaging modalities, ten different anatomically various medical datasets, encompassing more than 30 organs and tumor types. It outperforms the state-of-the-art task-specific and universal models on 8 out of 10 datasets. We demonstrate extensibility of its text-controlled architecture by seamless integration of electronic health record (EHR) data for prognosis prediction, and on a head and neck cancer dataset, DuPLUS achieved a Concordance Index (CI) of 0.69. Parameter-efficient fine-tuning enables rapid adaptation to new tasks and modalities from varying centers, establishing DuPLUS as a versatile and clinically relevant solution for medical image analysis. The code for this work is made available at: Code

Fields of Study & Subjects

Brain Tumor Detection and Classification Radiomics and Machine Learning in Medical Imaging AI in cancer detection

Publication details

Journal / source
2026 IEEE/CVF Winter Conference on Applications of Computer Vision (WACV)
Publisher
IEEE
Pages
8386–8395
Publication date
6 March 2026
Language
EN